Class I - Dangerous
Failed Tablet/Capsule Specifications; during an internal inspection, capsules were found with illegible print.
💊
Prescription Drugs
💊 Drugs • 11,927 recalls
Class I - Dangerous
Failed Impurities/Degradation Specifications: high out of specification results for one of the known degradation products, m-chlorobenzoic acid.
Class I - Dangerous
Chemical Contamination
Lumigan (bimatoprost ophthalmic solution) 0.01%, 7.5 mL bottle, Rx only, Allergan Irvine, CA 92612, NDC 0023-3205-08.
Allergan Sales
Class I - Dangerous
Failed Impurities/Degradation Specifications
Vancomycin HCl 750 mg added to 250 mL 0.9% Sodium Chloride For IV Use Only, Rx Only, SCA Pharmaceuticals, Little Rock, AR 72205, NDC 70004-0929-40
SCA Pharmaceuticals
Class I - Dangerous
Presence of particulate matter - this recall is due to a recent Hospira recall of vancomyicn hydrochloride 10gm vials due to presence of particulate matter.
Vancomycin HCl 1.25 g added to 0.9% Sodium Chloride 250 mL Bag For IV Use Only, Rx Only, SCA Pharmaceuticals, Little Rock, AR 72205, NDC 70004-0923-59
SCA Pharmaceuticals
Class I - Dangerous
Presence of particulate matter - this recall is due to a recent Hospira recall of vancomyicn hydrochloride 10gm vials due to presence of particulate matter.
Class I - Dangerous
Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib
Vancomycin HCl 1.5 g added to 0.9% Sodium Chloride 250 mL Bag For IV Use Only Rx Only, SCA Pharmaceuticals, Little Rock, AR 72205, NDC 70004-0924-59
SCA Pharmaceuticals
Class I - Dangerous
Presence of particulate matter - this recall is due to a recent Hospira recall of vancomyicn hydrochloride 10gm vials due to presence of particulate matter.
Class I - Dangerous
Presence of Particulate Matter: Glass
Class I - Dangerous
Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib
Class I - Dangerous
Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib
Class I - Dangerous
Defective Delivery System: Elevated number of units with out of specification results for leak rate.
Class I - Dangerous
Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib
Class I - Dangerous
Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib
Class I - Dangerous
Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib
Class I - Dangerous
Superpotent Drug: An oversized tablet was found in a bottle.
Class I - Dangerous
Presence of Particulate Matter
Fluphenazine Decanoate Injection, USP; 25 mg/mL, 5mL vials, Rx only, APP Pharmaceuticals, LLC Schaumburg, IL 60173, NDC 63323-0272-05
Fresenius Kabi USA
Class I - Dangerous
Subpotent Drug
Class I - Dangerous
Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib
Vancomycin HCl 750 mg added to 5% Dextrose 250 mL For IV Use Only, Rx Only, SCA Pharmaceuticals, Little Rock, AR 72205, NDC 70004-0918-40
SCA Pharmaceuticals
Class I - Dangerous
Presence of particulate matter - this recall is due to a recent Hospira recall of vancomyicn hydrochloride 10gm vials due to presence of particulate matter.